Literature DB >> 7078891

Estrogen levels in postmenopausal women with hot flashes.

Y Erlik, D R Meldrum, H L Judd.   

Abstract

Following menopause, some women are troubled by hot flashes (episodes of flushing and perspiration), whereas others do not experience the symptom. To determine whether the extent of estrogen deficiency influences the occurrence of the disturbance, the authors measured the levels of estradiol (E2), estrone (E1), and sex-hormone binding globulin (SHBG), and the percent and total non-SHBG-bound E2 in 24 women with frequent hot flashes and 24 women who had never experienced the symptom. Significantly lower levels of E2 (P less than .002), E1 (P less than .05), percent non-SHBG E2 (P less than .05), and total non-SHBG-bound E2 (P less than .01) were found in the symptomatic women. Similar differences were confirmed in 18 subject pairs matched for age, years since menopause, and presence or absence of ovaries. The finding of a significantly (P less than .05) lower percent ideal body weight in the women with hot flashes suggests that the known effects of body weight on the rate of extraglandular estrogen production and the level of SHBG in postmenopausal women may be important variables determining the occurrence of hot flashes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078891

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  31 in total

Review 1.  [Prevention of secondary manifestations of menopause. Pathophysiologic principles].

Authors:  M H Birkhäuser
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Current alcohol use, hormone levels, and hot flashes in midlife women.

Authors:  Chrissy Schilling; Lisa Gallicchio; Susan R Miller; Patricia Langenberg; Howard Zacur; Jodi A Flaws
Journal:  Fertil Steril       Date:  2007-02-02       Impact factor: 7.329

3.  Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study.

Authors:  Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2013-12-17       Impact factor: 2.681

4.  Estrogen replacement therapy.

Authors:  J R Higgin
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

5.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Authors:  Yiwei Wang; Gerson Hernandez; Wendy J Mack; Lon S Schneider; Fei Yin; Roberta D Brinton
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

Review 6.  Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.

Authors:  Daniel L Hertz; N Lynn Henry; James M Rae
Journal:  Pharmacogenomics       Date:  2017-03-27       Impact factor: 2.533

Review 7.  Menopausal symptoms as consequences of dysrhythmia.

Authors:  L Gannon
Journal:  J Behav Med       Date:  1993-08

8.  Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes.

Authors:  Ayelet Ziv-Gal; Lisa Gallicchio; Susan R Miller; Howard A Zacur; Jodi A Flaws
Journal:  Am J Obstet Gynecol       Date:  2012-06-01       Impact factor: 8.661

9.  Abdominal adiposity and hot flashes among midlife women.

Authors:  Rebecca C Thurston; MaryFran R Sowers; Kim Sutton-Tyrrell; Susan A Everson-Rose; Tené T Lewis; Daniel Edmundowicz; Karen A Matthews
Journal:  Menopause       Date:  2008 May-Jun       Impact factor: 2.953

10.  Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women.

Authors:  Erika Hyde Riley; Thomas S Inui; Ken Kleinman; Maureen T Connelly
Journal:  J Gen Intern Med       Date:  2004-07       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.